Figure 7.
Figure 7. TMTregs inhibit responder cell expansion and effector function but not Th1 differentiation. CD4+ T cells purified from 6.5 Tg mice (Thy1.1+/Thy1.2+) were labeled with CFSE and transferred as responder cells, either alone or together with an equal number of sorted TMTregs or effector cells (Thy1.1+/+), into BALB/c recipients. All mice received vacHA immunization the next day. (A) Cells from tail blood collected at the indicated time points were stained with anti-Thy1.1–PE and anti-Thy1.2–APC mAbs. Percentages of the gated populations are indicated. (B) Spleen cells were harvested, counted, and the absolute numbers of Thy1.1+/Thy1.2+ and Thy1.1+/+ cells were determined 5 days after vaccination. *P < .05; **P < .01. (C) The divided fractions of the Thy1.1+/Thy1.2+ and Thy1.1+/+ populations were sorted by FACS either separately or together and analyzed for proliferation and IFN-γ production in the presence of varied amounts of peptide. (D) In vitro suppression assay. Responder cells (Rag2–/– 6.5CD4+) were mixed with sorted cells at the indicated ratios in the presence of HA peptide and irradiated BALB/c splenocytes. The dotted line represents the proliferation of responders cultured alone with peptide and splenocytes; ▪, sorted responder cells when transferred alone; ▴, cotransferred responders and TMTregs sorted together; ×, separated responders when cotransferred with TMTregs; and □, separated TMTregs when cotransferred with responders. Results were shown as mean ± SE of triplicate cultures. The data shown are representative of 2 separate experiments. Similar results were obtained when TMTregs were transferred in excess of naive responder cells by a 2:1 ratio.

TMTregs inhibit responder cell expansion and effector function but not Th1 differentiation. CD4+ T cells purified from 6.5 Tg mice (Thy1.1+/Thy1.2+) were labeled with CFSE and transferred as responder cells, either alone or together with an equal number of sorted TMTregs or effector cells (Thy1.1+/+), into BALB/c recipients. All mice received vacHA immunization the next day. (A) Cells from tail blood collected at the indicated time points were stained with anti-Thy1.1–PE and anti-Thy1.2–APC mAbs. Percentages of the gated populations are indicated. (B) Spleen cells were harvested, counted, and the absolute numbers of Thy1.1+/Thy1.2+ and Thy1.1+/+ cells were determined 5 days after vaccination. *P < .05; **P < .01. (C) The divided fractions of the Thy1.1+/Thy1.2+ and Thy1.1+/+ populations were sorted by FACS either separately or together and analyzed for proliferation and IFN-γ production in the presence of varied amounts of peptide. (D) In vitro suppression assay. Responder cells (Rag2–/– 6.5CD4+) were mixed with sorted cells at the indicated ratios in the presence of HA peptide and irradiated BALB/c splenocytes. The dotted line represents the proliferation of responders cultured alone with peptide and splenocytes; ▪, sorted responder cells when transferred alone; ▴, cotransferred responders and TMTregs sorted together; ×, separated responders when cotransferred with TMTregs; and □, separated TMTregs when cotransferred with responders. Results were shown as mean ± SE of triplicate cultures. The data shown are representative of 2 separate experiments. Similar results were obtained when TMTregs were transferred in excess of naive responder cells by a 2:1 ratio.

Close Modal

or Create an Account

Close Modal
Close Modal